The healthcare investor conference MedCity INVEST, scheduled for May 20-21 at the Willis Tower in Chicago, will spotlight a wide range of topics from GLP-1 drug coverage to investment trends and more. Register today! The post What Are Health Systems’ Strategic Priorities in 2025? appeared first on MedCity News.
SACRAMENTO, Calif. — California has halted a court-ordered medical parole program, opting instead to send its most incapacitated prisoners back to state lockups or release them early. The unilateral termination is drawing protests from attorneys representing prisoners and the author of the state’s medical parole legislation, who say it unnecessarily puts this vulnerable population at…
The assisted living facility in Edina, Minnesota, where Jean Peters and her siblings moved their mother in 2011, looked lovely. “But then you start uncovering things,” Peters said. Her mother, Jackie Hourigan, widowed and developing memory problems at 82, too often was still in bed when her children came to see her midmorning. “She wasn’t…
By MATT McCORD Using opioids to treat acute pain is a lot like burning coal to power our homes. Both are legacy solutions from an earlier era. Both were once celebrated as breakthroughs. And both have since proven to be dirty, dangerous, and incredibly costly to clean up. Despite this, we continue to rely on…
The FDA approved Sanofi and Regeneron Pharmaceuticals drug Dupixent as a treatment for the inflammatory skin disorder chronic spontaneous urticaria. The regulatory decision comes two years after the agency turned down an application for the biologic drug in this indication. The post Blockbuster Sanofi & Regeneron Drug Dupixent Notches FDA Nod for an Inflammatory Skin…
Too many women have experienced the impacts of living with gynecological conditions while feeling dismissed and struggling to get care. Women deserve better, and as we collectively challenge outdated norms, we are beginning to see improvement. Still, there’s much more work to be done. The post Women’s Health is Having Its Moment – It’s Time for…
Although the healthcare industry has a long way to go before PGx testing for DPYD and other genes becomes widespread, it’s encouraging that regulatory bodies and professional organizations are making recommendations and raising awareness among healthcare providers. The post Drug-Gene Testing: Key to Safer Cancer Treatment appeared first on MedCity News.
The Trump administration’s steep tariffs on Chinese imports are threatening to further destabilize hospitals’ bottom lines by driving up the cost of essential supplies and exacerbating already fragile supply chains. As providers prepare for higher expenses and potential shortages, experts warn that these policies could wosen care quality and force hospitals to make tough financial…
UnitedHealth Group’s shares fell by over 22% on Thursday after its first quarter earnings. This is largely due to challenges in its Medicare Advantage business. The post Why UnitedHealth Group’s Shares Have Taken a Tumble appeared first on MedCity News.
Tariffs on pharmaceuticals. First, President Trump has voiced his goal to impose tariffs on pharmaceutical products made overseas. The New York Times reports: Mr. Trump said in remarks to reporters on Monday that pharmaceutical tariffs would come in the “not too distant future.”“We don’t make our own drugs anymore,” Mr. Trump said. “The drug companies…